Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Status:
Recruiting
Trial end date:
2025-10-12
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well celecoxib works through surgery and radiation therapy in
treating patients with head and neck cancer that has spread to other places in the body
(advanced). Celecoxib is Food and Drug Administration approved to treat arthritis, acute
pain, and painful menstrual periods. Adding celecoxib to standard of care treatment may help
to decrease the amount of time between surgery and radiation therapy.